FDA clears Toshiba's coincidence option
The Food and Drug Administration cleared Toshiba America Medical Systems' coincidence detection imaging software for its Toshiba E. Cam last month, according to Lin Sinclair, product manager for the company's nuclear medicine division. Toshiba's E.Cams
The Food and Drug Administration cleared Toshiba America Medical Systems' coincidence detection imaging software for its Toshiba E. Cam last month, according to Lin Sinclair, product manager for the company's nuclear medicine division. Toshiba's E.Cams are supplied by Siemens Medical Systems, and the Hoffman Estates, IL, vendor obtained a 510(k) for its E.Cam coincidence package in October 1997. Toshiba of Tustin, CA, was required to apply for its own clearance, however, because its version of E.Cam uses Sun Microsystems UltraSparc computers, rather than the Macintosh-based Icon computers employed in Siemens E.Cams.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
